PQ 1290
1290. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 745 of 8 May 2019, if the National Centre for Pharmacoeconomics has completed its full health technology assessment of the new anti-calcitonin gene-related peptide used for the preventative treatment of chronic migraine; and if he will make a statement on the matter. [22004/20]
Introduced
8 September 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 September 2020
Summary
1290. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 745 of 8 May 2019, if the National Centre for Pharmacoeconomics has completed its full health technology assessment of the new anti-calcitonin gene-related peptide used for the preventative treatment of chronic migraine; and if he will make a statement on the matter. [22004/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 8 September 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-09-08/1290/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-09-08/pq_1290